725743-45-3 Usage
Uses
Used in Pharmaceutical Applications:
1-(2,2-dimethylcyclopropyl)methanamine(SALTDATA: HCl) is used as a reagent in the pharmaceutical industry for its ability to participate in a range of chemical reactions. Its enhanced solubility due to the formation of a salt with HCl makes it a valuable component in the development of new drugs and medicinal compounds.
Used in Research Applications:
In the field of scientific research, 1-(2,2-dimethylcyclopropyl)methanamine(SALTDATA: HCl) serves as a crucial compound for exploring its chemical properties and potential interactions with other substances. Its unique structure allows researchers to investigate its behavior under various conditions, which can lead to advancements in understanding chemical reactions and the development of novel applications.
Used in Chemical Reactions:
As a reagent, 1-(2,2-dimethylcyclopropyl)methanamine(SALTDATA: HCl) is utilized in chemical reactions to facilitate specific transformations or to act as an intermediate in the synthesis of more complex molecules. Its cyclopropyl and amine groups offer unique opportunities for chemical modification and functionalization, making it a versatile component in organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 725743-45-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,5,7,4 and 3 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 725743-45:
(8*7)+(7*2)+(6*5)+(5*7)+(4*4)+(3*3)+(2*4)+(1*5)=173
173 % 10 = 3
So 725743-45-3 is a valid CAS Registry Number.
725743-45-3Relevant articles and documents
Piperazine derivatives and their use as therapeutic agents
-
Paragraph 0123, (2016/03/19)
Compounds for treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the compounds are of formula (I): where x y, W, V, R 2 , R 3 , R 4 , R 5 , R 6 , R 6a , R 7 , R 7a , R 8 , R 8a , R 9 and R 9a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
